Does Testosterone Interact with Repository Corticotropin?
CDI records a moderate classification for Testosterone and Repository Corticotropin. The stored summary is: Concurrent use with testosterone may result in increased fluid retention. Use with caution, particularly in patients with cardiac, renal, or hepatic disease. The mechanism involves increased fluid retention. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Testosterone Class
- Androgen
- Repository Corticotropin Class
- Adrenocorticotropic Hormone
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased fluid retention
What To Tell Your Doctor or Pharmacist
If you are taking Testosterone and your doctor is considering prescribing Repository Corticotropin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider